158 related articles for article (PubMed ID: 6479153)
1. Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.
Bayer H; Gruber W; Schneider J; Hunsmann G
EMBO J; 1984 Aug; 3(8):1925-30. PubMed ID: 6479153
[TBL] [Abstract][Full Text] [Related]
2. Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.
Bayer H; Hunsmann G
J Gen Virol; 1987 Feb; 68 ( Pt 2)():515-22. PubMed ID: 3469323
[TBL] [Abstract][Full Text] [Related]
3. Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.
Nick S; Klaws J; Friebel K; Birr C; Hunsmann G; Bayer H
J Gen Virol; 1990 Jan; 71 ( Pt 1)():77-83. PubMed ID: 1689371
[TBL] [Abstract][Full Text] [Related]
4. Glycoproteins of friend murine leukemia virus: separation and NH2-terminal amino acid sequences of gp69 and gp71.
Linder D; Stirm S; Schneider J; Hunsmann G; Smythers G; Oroszlan S
J Virol; 1982 Apr; 42(1):352-5. PubMed ID: 7086961
[TBL] [Abstract][Full Text] [Related]
5. Immunoprevention of Friend leukaemia virus-induced erythroleukaemia by vaccination with aggregated gp70.
Kleiser C; Schneider J; Bayer H; Hunsmann G
J Gen Virol; 1986 Sep; 67 ( Pt 9)():1901-7. PubMed ID: 2427646
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a protein found in cells infected with the spleen focus-forming virus that shares immunological cross-reactivity with the gp70 found in mink cell focus-inducing virus particles.
Ruscetti SK; Linemeyer D; Feild J; Troxler D; Scolnick EM
J Virol; 1979 Jun; 30(3):787-98. PubMed ID: 90166
[TBL] [Abstract][Full Text] [Related]
7. Rosettes from Friend leukemia virus envelope: preparation and physicochemical and partial biological characterization.
Schneider J; Schwarz H; Hunsmann G
J Virol; 1979 Feb; 29(2):624-32. PubMed ID: 85724
[TBL] [Abstract][Full Text] [Related]
8. Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies.
Elder JH; McGee JS; Munson M; Houghten RA; Kloetzer W; Bittle JL; Grant CK
J Virol; 1987 Jan; 61(1):8-15. PubMed ID: 2431166
[TBL] [Abstract][Full Text] [Related]
9. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library.
Dybwad A; Førre O; Kjeldsen-Kragh J; Natvig JB; Sioud M
Eur J Immunol; 1993 Dec; 23(12):3189-93. PubMed ID: 7504991
[TBL] [Abstract][Full Text] [Related]
10. Group-specific cytolytic antibody directed against the major glycoprotein (gp70) of murine leukemia viruses in serum of mice with dormant FLV infections.
Callahan RM; Marx PA; Wheelock EF
Virology; 1979 Aug; 97(1):55-67. PubMed ID: 224581
[No Abstract] [Full Text] [Related]
11. [Structural proteins of C-type RNA tumor viruses. Properties and significance for tumor immunity].
Hunsmann G
Fortschr Med; 1977 Oct; 95(39):2394. PubMed ID: 72034
[TBL] [Abstract][Full Text] [Related]
12. Properties of mouse leukemia viruses. VIII. The major viral glycoprotein of Friend leukemia virus. Seroimmunological, interfering and hemagglutinating capacities.
Hunsmann G; Moennig V; Pister L; Seifert E; Schäfer W
Virology; 1974 Dec; 62(2):307-18. PubMed ID: 4139810
[No Abstract] [Full Text] [Related]
13. Spontaneous regression of Friend virus-induced erythroleukemia. VI. Structural and antigenic differences between the regressing and conventional strains of virus.
Furmanski P; Longley C; Bolles CS; Hines DL; Dietz M
J Virol; 1980 Mar; 33(3):1083-96. PubMed ID: 6928980
[TBL] [Abstract][Full Text] [Related]
14. A glycoprotein specified by spleen focus-forming virus in three cell lines varies on molecular size and peptide composition, but retains both xenotropic and ecotropic MuLV antigenicity.
Yoshida M; Yoshikura H
J Gen Virol; 1981 Jan; 52(Pt 1):183-8. PubMed ID: 6267174
[TBL] [Abstract][Full Text] [Related]
15. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus.
Chesebro B; Britt W; Evans L; Wehrly K; Nishio J; Cloyd M
Virology; 1983 May; 127(1):134-48. PubMed ID: 6305011
[TBL] [Abstract][Full Text] [Related]
17. Characterization of structural and immunological properties of specific domains of Friend ecotropic and dual-tropic murine leukemia virus gp70s.
Pinter A; Honnen WJ
J Virol; 1984 Feb; 49(2):452-8. PubMed ID: 6198530
[TBL] [Abstract][Full Text] [Related]
18. Isolation and comparison of murine leukemia virus-related glycoproteins from AKR and New Zealand mice.
Kennel SJ
J Virol; 1977 Apr; 22(1):168-74. PubMed ID: 192911
[TBL] [Abstract][Full Text] [Related]
19. Successful use of oligopeptides as immunogens in the preparation of antisera to immediate-early gene products of herpes simplex virus type 1.
Palfreyman JW; Maclean JB; Messeder E; Sheppard RC
J Gen Virol; 1984 May; 65 ( Pt 5)():865-74. PubMed ID: 6202828
[TBL] [Abstract][Full Text] [Related]
20. Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus.
Bolognesi DP; Collins JJ; Leis JP; Moennig V; Schäfer W; Atkinson PH
J Virol; 1975 Dec; 16(6):1453-63. PubMed ID: 53293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
